Qinxin Zhao

Statistics

Publications

Citations

837

H-Index

Active since

2019

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Shanxi Medical University

Beijing Chao-Yang Hospital, Capital Medical University

Capital Medical University

Chinese Academy of Sciences

Qinxin Zhao is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2019–2023

Publications

Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy

Boda Guo, Feiya Yang, Lingpu Zhang et al. · Advanced Materials · 2023 · 383 citations

Life Sciences, Cancer Biology, Oncology +17

Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways

Xinxing Lu, Feiya Yang, Dexi Chen et al. · International Journal of Biological Sciences · 2020 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy (Adv. Mater. 22/2023)

Boda Guo, Feiya Yang, Lingpu Zhang et al. · Advanced Materials · 2023 · 90 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF‐κB, MAPKs, and Nrf2 signaling pathways in rats

Qinxin Zhao, Feiya Yang, Lingquan Meng et al. · Andrology · 2019 · 78 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death

Liyuan Wu, Fei Liu, Le Yin et al. · Cancer Communications · 2022 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 7